The Medicines (Products for Human Use) (Fees) Regulations 2016
- 3Interpretation of Part 2
- 3aFee for scientific or other advice
- 4Fee for scientific advice: application for, or variation to, EU marketing authorisation
- 5Fee for scientific advice: classification of a medicinal product
- 6Fee for advertising advice
- 7Fee for pharmacovigilance advice
- 8Fee for advice on labelling or leaflets
- 9Fee for regulatory advice
- 10Fee for advice for other purposes
- 10aWaiver for advice given to small and medium companies
- 11Time for payment of fees under regulations 3A to 8
- 12Fees for applications for authorisations, registrations, licences or certificates etc.
- 13Fee for application to be included on the list of online sellers of medicines
- 14Fee for applications for additional copy certificates
- 15Fees for applications for certificates and copy certificates by exporters of medicinal products
- 19Fees for variations of authorisations, registrations and licences
- 19aFees for certification of plasma master files
- 19bFee for certification of vaccine antigen master files
- 19cFees for assessment of post-authorisation safety studies
- 19dFee for carrying out a major safety review
- 19eFee for assessment of periodic safety update reports
- 19eaFee for assessment of clinical trial annual safety reports
- 19fFee for testing of samples by the appropriate authority
- 19gTime for payment of fees under regulations 19A to 19F
- 20Fees for modifications to clinical trial authorisations
- 21Fees for notification of changes and reports for broker's registrations
- 22Fees for notification of changes and compliance Reports for active substance registrations
- 23Applications for multiple variations
- 30Fees for inspections
- 31Fees for inspections of pharmacovigilance service providers
- 32Payer of inspection fee (contract laboratories and API manufacturing sites)
- 33Inspections in connection with multiple applications
- 34Fees for inspections relating to good clinical practice in clinical trials
- 35Amount, and time for payment, of inspection fees in respect of an application for a wholesale dealer's lice
- 36Adjustment and refund of inspection fees in respect of a wholesale dealer's licence
- 37Amount, and time for payment, of inspection fees in respect of an application for a broker's registration o
- 49Payment of fees to Ministers
- 50Time for payment of capital fees in connection with applications or inspections
- 51Time for payment of capital fees – applications made by small companies
- 52Payment of fees in respect of a traditional herbal registration
- 53Time for payment of periodic fees
- 54Penalty fees for late payment of periodic fees
- 55Daily penalty fees for late payment of periodic fees
- 56Refund or waiver of fees under regulation 54 or 55
- 57Adjustment, waiver, reduction or refund of fees
- 58Suspension of licences and authorisations
- 59Civil proceedings to recover unpaid fees
1 General: interpretation and categories of applications and variations
- 1Interpretation
- 2General: categories of Applications and Variations
- 3Administrative variation application
- 4Extension application
- 5Complex application
- 6Complex registration application
- 7Complex variation application
- 8Decentralised procedure application
- 9Extended Type II Complex Variation Application
- 10Major application
- 11Mutual recognition procedure incoming application
- 12New excipient variation application
- 13New indication variation application
- 14Parallel Import Licence application
- 15Reclassification variation application
- 16Reduced registration application
- 17Simple application
- 18Standard application
- 19Standard registration application
- 20Standard variation application
- 21Standard variation application for a homoeopathic medicinal product
- 22Type IB and Type II Applications
- 23Type II Complex Variation Application
2 Capital Fees for Applications for Authorisations, Licences, Registrations and Certificates
- 24Marketing authorisations
- 24aFees where an application for a European Union marketing authorisation had been made before IP completion
- 25Fees where application includes reclassification
- 26Fees where person holds clinical trial certificate
- 27Joint development
- 28Application for multiple authorisations
- 28aApplication by pre-assessment of modules
- 29Authorisation for a national homoeopathic product
- 30Manufacturer's licences and authorisations
- 31Wholesale dealer's licences
- 32Broker's registrations
- 33Active substance registrations
- 34Clinical trial authorisations
- 35Traditional herbal registrations
- 35aEarly Access to Medicines Scheme fees
- 36Online sellers of medicines
3 Capital Fees for Assistance in Obtaining Marketing Authorisations in Other EEA States
4 Capital Fees for Applications for Variations of Authorisations, Licences and Registrations
- 38Marketing authorisations
- 39Variation of marketing authorisations
- 39aVariation of orphan marketing authorisations: small and medium companies
- 40Reclassification of marketing authorisations
- 40aFees where an application for a variation or an extension of a European Union marketing authorisation had
- 41Variation of marketing authorisation: national homoeopathic products
- 42Variation of parallel import licence
- 43Manufacturer's authorisations and licences
- 44Variation of manufacturer's authorisations and licences
- 45Wholesale dealer's licences
- 46Variation of wholesale dealer's licence
- 47Variation of a broker's registration
- 48Variation of an active substance registration
- 49Clinical trial authorisations
- 50Traditional herbal registrations
- 51Identical variations
- 52Complex Variation Applications
- 53Multiple reclassification variation applications
5 Capital Fees for Assessment of Labels and Leaflets
6 Capital Fee for the Renewal of a Marketing Authorisation
6A Capital Fee for Conducting a Major Safety Review
6B Capital Fee for Testing of Samples by the Appropriate Authority
- 1General provisions relating to fees for inspections
- 2Fees: general
- 3Traditional herbal medicinal products
- 4Sites concerned with starting materials for traditional herbal medicinal products
- 5Wholesale dealer's licence: general
- 6Wholesale dealer's licence: traditional herbal medicinal products
- 7Wholesale dealer's licences: inspection of short duration
- 8Broker's registrations
- 9Active substance registrations
- 10Office-based inspections
2 Value of the Product Sold or Supplied
3 Periodic Fees for Marketing Authorisations and Licences
- 5Marketing authorisations
- 6Marketing authorisation: where Part 2 of the Act applies
- 7Marketing authorisation: derivatives
- 8Number of fee periods
- 9Authorisation for two or more kinds of medicinal product
- 10Reduced fees
- 11Manufacturer's licences or manufacturing authorisations
- 12Wholesale dealer's licences
- 13Wholesale dealer's licences: evidence
- 14Wholesale dealer's licences: special medicinal products
- 15Additional amount for manufacturer's licences and wholesale dealer's licences which relate to special medic
- 16Traditional herbal registrations
- 17Online sellers of medicines
4 Types of Marketing Authorisation for which only One Periodic Fee is Payable
- 1Interpretation
- 2Major application
- 3Complex application
- 4Multiple application
- 5Outgoing mutual recognition application
- 6Application for traditional herbal registration
- 7Traditional herbal registration: complex variation
- 8Application for manufacturer's licence, manufacturing authorisation or wholesale dealer's licence
- 9Inspection fees in connection with applications
- 1Interruptions of manufacture, assembly, sale or supply
- 2Reclassification
- 3Variation of a traditional herbal registration
- 4Withdrawal of application in relation to marketing authorisation, traditional herbal registration or clinica
- 5Withdrawal of application in relation to a certificate of registration
- 6Withdrawal of application in relation to manufacturing authorisation, wholesale dealer's licence, manufactur
- 7Refusal of application for grant of marketing authorisation, traditional herbal registration or clinical tri
- 7aOrphan marketing authorisation
- 8Parallel import licence
- 9Surrender of marketing authorisation at same time as a variation application
- 10Clinical trial authorisation
- 11Scientific advice: paediatric indications
- 12Refunds: treated as having been paid on account
Source: legislation.gov.uk (The National Archives), UK legislation with its point-in-time versions. Official publication. Reuse: Open Government Licence v3.0.